Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study

BACKGROUND: Treatment of congenital hemophilia A (HA) in Japan has greatly improved with the widespread adoption of prophylactic factor (F)VIII concentrates. However, it is unknown if this has translated into a real‐world reduction in disease and treatment burden. OBJECTIVES: To describe HA disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagao, Azusa, Ioka, Akiko, Nakamura, Takao, Murakami, Yoichi, Makishima, Misako, Okada, Norihiro, Sakai, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615292/
https://www.ncbi.nlm.nih.gov/pubmed/36320425
http://dx.doi.org/10.1002/rth2.12825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615292/
https://www.ncbi.nlm.nih.gov/pubmed/36320425
http://dx.doi.org/10.1002/rth2.12825

Ejemplares similares